Inactive Instrument

Curable. Inc. Share Price

A086460

KR7086460003

Biotechnology & Medical Research

Curable Inc, SNP Genetics Inc, is a Korea-based company mainly engaged in the analysis of genomes. The company is involved in the research and development of disease-related single nucleotide polymorphism (SNP) contents using SNP. These diseases include asthma, diabetes, osteoporosis, alcoholism, tuberculosis, cancer, multiple sclerosis, obesity, mental illness, metabolic disease, lupus disease. The Company is involved in the production and sale of Kobreed kits, as well as the provision of SNP Care. The Kobreed kits are medicine for discriminating Korean beef and imported meat. SNP Care is a gene analysis service. In addition, the Company is engaged in leasing of the places of business. The major customers include government agencies such as the Disease Control Headquarters and the Food and Drug Administration.

Employees

Sector

Biotechnology & Medical Research

More about the company

Stock Market
Stocks
A086460 Stock

The best tools reserved for subscribers to boost the performance of your investments!

30/03/25	JS Investment Fund cancelled the acquisition of 37.42% stake in Curable. Inc. from GW Vitek CO.,LTD..	CI
24/11/24	JS Investment Fund signed a letter of intent to acquire 37.42% stake in Curable. Inc. from GW Vitek CO.,LTD. for KRW 5.5 billion.	CI
19/01/23	Curable. Inc. agreed to acquire 8.5% stake in Pharma Biotech Korea Co., Ltd from Pharma Biotech Korea for KRW 8.5 billion.	CI
18/01/23	Curable. Inc. announced that it has received KRW 5.0009986 billion in funding from GW Vitek CO.,LTD.	CI
22/05/22	SNP Genetics Inc. announced that it has received KRW 10 billion in funding from Kalis BNT Co., Ltd.	CI
18/05/22	Curable. Inc. announced that it expects to receive KRW 9.999995 billion in funding from GW Vitek CO.,LTD.	CI
15/05/22	SNP Genetics Inc. announced that it expects to receive KRW 10 billion in funding from Kalis BNT Co., Ltd.	CI
18/04/22	An unknown buyer agreed to acquire 16.82% of stake in SNP Genetics Inc. from Jo, Jin-hwan and others for KRW 3.7 billion.	CI
13/04/22	SNP Genetics Inc. announced that it has received KRW 2.49999872 billion in funding	CI
05/04/22	SNP Genetics Inc. announced that it expects to receive KRW 2 billion in funding	CI
05/04/22	SNP Genetics Inc. announced that it expects to receive KRW 2.49999872 billion in funding	CI
20/02/22	GW Vitek CO.,LTD. agreed to acquire a 40.7% stake in SNP Genetics Inc. from Hyoung-doo Shin and Myung-cheol Kim for KRW 9.4 billion.	CI
05/02/21	Tranche Update on SNP Genetics Inc.'s Equity Buyback Plan announced on November 2, 2020.	CI

Manager	Title	Age	Since
Tae-Yong Cho CEO	Chief Executive Officer	61	28/04/2025
Myung-Won Seo CEO	Chief Executive Officer	57	30/04/2023
Han-Kyung Kim AUD	Comptroller/Controller/Auditor	52	-

Director	Title	Age	Since
Jae-Won Yang BRD	Director/Board Member	56	-
Sang-Rae Lee BRD	Director/Board Member	54	-
Jong-Seon Lee BRD	Director/Board Member	55	-

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
CURABLE. INC.	-17.54%	-84.18%	-	-	4.64K
VERACYTE, INC.	-2.09%	+9.61%	+118.13%	+131.49%	4.8B
ADAPTIVE BIOTECHNOLOGIES CORPORATION	-2.71%	+20.89%	+78.80%	+210.43%	3.42B
BGI GENOMICS CO., LTD.	+3.58%	-1.86%	-26.99%	-40.38%	2.03B
IOVANCE BIOTHERAPEUTICS, INC.	-0.59%	-6.16%	+142.23%	-40.82%	1.88B
CAREDX, INC.	-3.59%	+12.06%	+44.06%	+231.18%	1.51B
MARAVAI LIFESCIENCES HOLDINGS, INC.	-4.07%	+16.48%	+159.54%	-49.68%	943M
SEEGENE, INC.	+8.75%	+12.36%	-7.73%	+47.82%	910M
CURIOX BIOSYSTEMS CO., LTD	+17.16%	-7.72%	+16.56%	-	506M
HANGZHOU ALLTEST BIOTECH CO., LTD.	+1.59%	-4.87%	-37.37%	-18.92%	474M
Average	+0.14%	+10.38%	+54.14%	+58.89%	1.83B
Weighted average by Cap.	-0.19%	+12.62%	+75.88%	+95.85%

Curable. Inc. Share Price

Stocks

A086460

KR7086460003

Biotechnology & Medical Research

Chart: Curable. Inc.

Latest news : Curable. Inc.

Quotes and Performance

Managers and Directors: Curable. Inc.

Bio Diagnostics & Testing

Company Profile